Abstract
A new series of ether derivatives of dihydroartemisinin have been prepared and evaluated for their antimalarial activity against multidrug-resistant Plasmodium yoeliinigeriensis in mice by oral route. These new derivatives 7 − 17 are highly lipophilic (log P in the range of 5.51 to 7.19) as compared with β-arteether (log P 3.84), and several of them are two- to four-fold more active than β-arteether. Among the ether derivatives, α-isomers are more active than the β-isomers. The ether derivatives 12α and 14α, the most active compounds of the series, provided 100% protection to infected mice at 12 mg/kg × 4 days. In this model β-arteether provides 100% and 20% protection at 48 mg/kg × 4 days and 24 mg/kg × 4 days, respectively.

This publication has 15 references indexed in Scilit: